Nuage

Seed
nuagetx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Jun 21, 2023
Investors Undisclosed
Decision Makers 2 Available

About Nuage

Unlocking the druggability of intrinsically disordered proteins to deliver a new wave of transformative cancer therapies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website nuagetx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Nuage.

Funding History

1 Round
Seed equity · Jun 21, 2023

Founders & Leadership

3

Denes Hnisz

Founder and Observer

Work email & phone locked Unlock →

Mateusz Biesaga

Founder and Chief Technology Officer

Work email & phone locked Unlock →

Xavier Salvatella

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts